Intravitreal gas (gas tamponade; e.g., C3F8)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intravitreal gas (gas tamponade; e.g., C3F8), covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). [Phase 3]